|
The Van Slyke Foundation is AACC’s philanthropic program, dedicated to encouraging and supporting deserving clinical laboratory scientists and students around the world through a variety of grants, awards, scholarships and other programs designed to share the latest and best in clinical laboratory science and technology and improve health care worldwide.
|
|
|
|
| Predicting Post-Treatment Prostate Cancer Outcomes | | Several studies have associated post-treatment prostate-specific antigen (PSA) nadir with prostate cancer outcomes. However, most of these analyses have evaluated absolute PSA nadir, which poses statistical challenges since PSA nadir is a time-dependent variable. | |
| | Nominations Being Accepted for the 2010 SYCL Service Award | | This award recognizes a SYCL member who has demonstrated exceptional contributions to the field of clinical chemistry through service to AACC. The recipient will be recognized and given an honorary plaque at the SYCL Reception at the 2010 Annual AACC meeting. The deadline is April 30, 2010. | |
| | Nominations for Carl Jolliff Award | | The Clinical and Diagnostic Immunology Division invites nominations of individuals deserving recognition for lifetime achievement in the field of clinical and diagnostic immunology. Sponsored by Beckman Coulter and named in honor of Carl Jolliff, the award is open to current AACC members. | |
| | Receive a 10% discount on AACC Press Web orders! | | Receive a 10% discount on any publication ordered through AACC Online Bookstore during our winter sale. If you are an AACC member, the discount will be in addition to your regular member discount. To receive your discount, enter promotion code 90 after you place your first item in the shopping cart and press "apply." Offer good from now through March 31, 2010. | |
|
|
|
|
|
|
| CytoDyn commences full humanization of Cytolin immune therapy for treating HIV/AIDS | | CytoDyn, Inc. has begun full humanization of Cytolin®, the Company’s unique immune therapy for treating HIV/AIDS. Although a murine (mouse) version of Cytolin® was used for previous human experience that included some 200 patients successfully treated for up to two years, as well as an encouraging Phase I(b)/II(a) study, the Company believes that a fully-humanized version is necessary for the clinical trial that is expected to follow the current one (described at http://clinicaltrials.gov) for the reasons explained below. |
| | Obama to appear on Fox News; Heath reform will be high on his topic list | | New York Times: President Obama is scheduled to give an interview with Bret Baier of Fox News Wednesday evening. The interview comes "at the height of a week in which Democrats, including Mr. Obama, are pressing allies and lawmakers to push ahead to get the health care bill passed in the House despite solid Republican opposition and the lessening of public support for the legislation." The interview comes after Obama administration aides last year criticized Fox News for its political coverage and commentary (3/16). |
| | Nabi Biopharmaceuticals commences second Phase III study of NicVAX for treating nicotine addiction | | Nabi Biopharmaceuticals announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary vaccine to treat nicotine addiction and prevent smoking relapse. The FDA has agreed with Nabi on the study design, protocol and end points through a Special Protocol Assessment (SPA). The SPA forms a basic foundation to support approval of a New Drug Application. The Company also received scientific advice from the European Medicines Agency (EMEA) that confirms and supports the trial protocol. |
| | Cut looms for Medicare payments to doctors | | Marketwatch/The Seattle Times reports on the looming 21 percent cut to physicians' Medicare payments. "The cut was to take effect March 1 until Congress delayed it by 30 days. The Senate then voted last Wednesday to postpone the cut an additional six months as part of a larger bill that extends unemployment benefits. The measure now moves to the House." |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
AACC (American Association for Clinical Chemistry) AACC is a leading professional society dedicated to improving healthcare through laboratory medicine. Its nearly 10,000 members are clinical laboratory professionals, physicians, research scientists, and others involved in developing tests and directing laboratory operations. AACC brings this community together with programs that advance knowledge, expertise, and innovation. AACC is best known for the respected scientific journal Clinical Chemistry, the award-winning patient-centered web site Lab Tests Online, and the world’s largest conference on laboratory medicine and technology. Through these and other programs, AACC advances laboratory medicine and the quality of patient care. Join AACC.
|
|
|
|